XML 43 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current Assets    
Cash and cash equivalents $ 17,525us-gaap_CashAndCashEquivalentsAtCarryingValue $ 14,625us-gaap_CashAndCashEquivalentsAtCarryingValue
Prepaid expenses and other current assets 1,548us-gaap_PrepaidExpenseAndOtherAssetsCurrent 1,591us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total Current Assets 19,073us-gaap_AssetsCurrent 16,216us-gaap_AssetsCurrent
Property and equipment, net 65us-gaap_PropertyPlantAndEquipmentNet 37us-gaap_PropertyPlantAndEquipmentNet
Deposits and other assets 6syn_DepositsAndOtherAssetsNoncurrent 4syn_DepositsAndOtherAssetsNoncurrent
Total Assets 19,144us-gaap_Assets 16,257us-gaap_Assets
Current Liabilities:    
Accounts payable 996us-gaap_AccountsPayableCurrent 142us-gaap_AccountsPayableCurrent
Accrued expenses 1,298us-gaap_AccruedLiabilitiesCurrent 882us-gaap_AccruedLiabilitiesCurrent
Warrant liabilities 6,756syn_WarrantLiabilities 0syn_WarrantLiabilities
Accrued employee benefits 538us-gaap_AccruedEmployeeBenefitsCurrent 3us-gaap_AccruedEmployeeBenefitsCurrent
Total Current Liabilities 9,588us-gaap_LiabilitiesCurrent 1,027us-gaap_LiabilitiesCurrent
Total Liabilities 9,588us-gaap_Liabilities 1,027us-gaap_Liabilities
Commitments and Contingencies 0us-gaap_CommitmentsAndContingencies 0us-gaap_CommitmentsAndContingencies
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued and outstanding 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue
Common stock, $0.001 par value; 100,000,000 shares authorized, 72,594,626 issued and 72,513,144 outstanding and 58,295,808 issued and 58,214,326 outstanding 72us-gaap_CommonStockValue 58us-gaap_CommonStockValue
Additional paid-in capital 110,526us-gaap_AdditionalPaidInCapitalCommonStock 96,430us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated deficit (101,042)us-gaap_RetainedEarningsAccumulatedDeficit (81,258)us-gaap_RetainedEarningsAccumulatedDeficit
Total Synthetic Biologics, Inc. and Subsidiaries Equity 9,556us-gaap_StockholdersEquity 15,230us-gaap_StockholdersEquity
Non-controlling interest 0us-gaap_MinorityInterest 0us-gaap_MinorityInterest
Total Stockholders’ Equity 9,556us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 15,230us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total Liabilities and Stockholders’ Equity $ 19,144us-gaap_LiabilitiesAndStockholdersEquity $ 16,257us-gaap_LiabilitiesAndStockholdersEquity